| Announce Date | 10/31/2025 |
| EPS Normalized Actual | $1.57 (Beat by $0.13) |
| EPS GAAP Actual | $1.57 (Beat by $0.13) |
| Revenue Actual | $11.994B |
| Revenue Surprise | Beat by $11994M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.75313 |
| EPS GAAP Estimate | $2.75313 |
| Revenue Estimate | $11.621498152B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 14.05494 | 5.95 | 7.92741 | 17.88338 | 1 |
| Dec 2028 | 9.64391 | 8.67 | 8.15275 | 11.83845 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.07 | -1.38043 | 11.994B | -10.55% | 662.18M |
| FQ2 2025 (Jun 2025) | 1.86 | 1.86 | 10.836B | -23.5% | 10836M |
| FQ1 2025 (Mar 2025) | 2.53 | 2.53 | 12.517B | 6.86% | 12517M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 11.92B | -49.79% | 11920M |
| FQ3 2024 (Sep 2024) | 2.33 | 2.33 | 13.259B | -4.99% | 13259M |
| FQ2 2024 (Jun 2024) | 2.11 | 2.11 | 13.383B | 11.69% | 13383M |
| FQ1 2024 (Mar 2024) | 2.23 | 2.23 | 11.658B | -3.97% | 11658M |
| FQ4 2023 (Dec 2023) | 3.36 | 3.36 | 17.8546B | 19.05% | 17854.6M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.75313
Consensus Revenue Estimates
11.621498152B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.73312 | -- | 1.51074 | 1.88025 | 1 |
| FQ3 2027 (Sep 2027) | 1.85631 | -- | 1.85631 | 1.85631 | 1 |
| FQ2 2027 (Jun 2027) | 1.81487 | -- | 1.81487 | 1.81487 | 1 |
| FQ1 2027 (Mar 2027) | 1.74281 | -- | 1.74281 | 1.74281 | 1 |
| FQ4 2026 (Oct 2026) | 2.15596 | -- | 2.12408 | 2.18784 | 0 |
| FQ3 2026 (Jul 2026) | 2.05394 | 47.91 | 2.02356 | 2.08432 | 0 |
| FQ2 2026 (Jun 2026) | 2.09994 | 11.43 | 2.07212 | 2.12776 | 0 |
| FQ1 2026 (Mar 2026) | 2.02585 | -24.89 | 1.78904 | 2.36179 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.26B | -- | 5.64B | 6.67B | 1 |
| FQ3 2027 (Sep 2027) | 6.39B | -- | 6.39B | 6.39B | 1 |
| FQ2 2027 (Jun 2027) | 6.33B | -- | 6.33B | 6.33B | 1 |
| FQ1 2027 (Mar 2027) | 5.92B | -- | 5.92B | 5.92B | 1 |
| FQ4 2026 (Oct 2026) | 9.33B | -- | 9.23B | 9.44B | 0 |
| FQ3 2026 (Jul 2026) | 8.79B | -36.45 | 8.69B | 8.89B | 0 |
| FQ2 2026 (Jun 2026) | 6.79B | -59.59 | 6.72B | 6.86B | 1 |
| FQ1 2026 (Mar 2026) | 8.39B | -49.19 | 7.64B | 9.46B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.45043 | 1.07 | -1.38043 | -129.01% |
| FQ2 2025 (Jun 2025) | 1.86 | 1.86 | 100% | |
| FQ1 2025 (Mar 2025) | 2.53 | 2.53 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 2.33 | 2.33 | 100% | |
| FQ2 2024 (Jun 2024) | 2.11 | 2.11 | 100% | |
| FQ1 2024 (Mar 2024) | 2.23 | 2.23 | 100% | |
| FQ4 2023 (Dec 2023) | 3.36 | 3.36 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $11.33B | $11.99B | $662.18M | 5.52% |
| FQ2 2025 (Jun 2025) | $0B | $10.84B | $10836M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $12.52B | $12517M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $11.92B | $11920M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $13.26B | $13259M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $13.38B | $13383M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $11.66B | $11658M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $17.85B | $17854.6M | 100% |